University of Michigan Cancer Center

Ann Arbor, Michigan 48197

2 studies enrolling now · 71 studies all time

What they study most

ACC, Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Adrenal Cancer, Adrenocortical Carcinoma, B-Cell Malignancies, Bladder Cancer, Brain Cancer, Brain Tumor, Brain Tumor, Primary

Studies at this site

• Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer — Recruiting now
• Metastatic Leiomyosarcoma Biomarker Protocol — Recruiting now
• The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study) — Running, not enrolling
• Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) — Running, not enrolling
• A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer — Running, not enrolling
• A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer — Running, not enrolling
• Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck — Running, not enrolling
• Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients — Completed
• Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma — Completed
• FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) — Completed
• Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer — Running, not enrolling
• A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) — Completed
• Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab — Stopped early
• ONC201 in Pediatric H3 K27M Gliomas — Stopped early
• Registry of Patients Treated With Systemic Mold-Active Triazoles — Completed
• A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer — Completed
• Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs — Completed
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) — Completed
• Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer — Completed
• A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Completed
• Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations — Stopped early
• A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer — Completed
• Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer — Completed
• A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis — Completed
• Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer — Status unconfirmed
• A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase — Completed
• A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies — Completed
• An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis — Completed
• Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer — Completed
• A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas — Withdrawn before enrolling
• Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas — Completed
• A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease — Completed
• Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant — Completed
• Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma — Completed
• Hypofractionated Stereotactic Body Radiation Therapy (SBRT) — Completed
• Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant — Completed
• A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response — Completed
• Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer — Completed
• Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen — Completed
• Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer — Completed
• Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients — Completed
• A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer — Completed
• A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors — Stopped early
• Trial Of Double Umbilical Cord Blood Transplantation — Completed
• Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha — Stopped early
• Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma — Completed
• A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma — Completed
• Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia — Completed
• Combination Chemotherapy Treatments in Patients With Metastatic Colorectal Cancer — Completed